Flush Syringe PosiFlush 4% Sodium Citrate Lock

Maintaining catheter patency and preventing catheter-related bloodstream infections (CRBSIs) are central goals in vascular access management. BD PosiFlushƒ?›pre-filled syringes are uniquely designed to standardize and enhance best clinical practice for improved patient outcomes and greater clinical efficiency. New 4% sodium citrate lock solution, BD PosiFlushƒ?›pre-filled syringes is recommended by clinical practice guidelines as an alternative to heparin,14% sodium citrate provides equivalent catheter patency while offering an improved safety profile, reduction in the risk of CRBSIs and prevention of biofilm formation

• Similar antithrombotic efficacy and maintenance of catheter function vs heparin 5,000ƒ??10,000 U/mL.
• May help prevent biofilm formation
• Improve CVC dwell time